Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06374602
Status:
RECRUITING
Last Update Posted:
2024-04-18
First Post:
2024-03-27
Brief Title:
Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Sponsor:
Organization:
Saint Petersburg State University Russia